2seventy bio (TSVT) Revenue & Revenue Breakdown
2seventy bio Revenue Highlights
Latest Revenue (Y)
$100.39M
Latest Revenue (Q)
$8.97M
Main Segment (Y)
Service
2seventy bio Revenue by Period
2seventy bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $100.39M | 9.72% |
| 2022-12-31 | $91.50M | 67.81% |
| 2021-12-31 | $54.52M | -78.03% |
| 2020-12-31 | $248.12M | 460.15% |
| 2019-12-31 | $44.30M | -18.84% |
| 2018-12-31 | $54.58M | - |
2seventy bio generated $100.39M in revenue during NA 2023, up 9.72% compared to the previous quarter, and up 183.93% compared to the same period a year ago.
2seventy bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $8.97M | -27.89% |
| 2024-03-31 | $12.44M | 16.39% |
| 2023-12-31 | $10.68M | -11.22% |
| 2023-09-30 | $12.03M | -66.62% |
| 2023-06-30 | $36.05M | -13.39% |
| 2023-03-31 | $41.62M | -25.91% |
| 2022-12-31 | $56.18M | 318.98% |
| 2022-09-30 | $13.41M | -0.55% |
| 2022-06-30 | $13.48M | 59.95% |
| 2022-03-31 | $8.43M | -47.43% |
| 2021-12-31 | $16.03M | -16.74% |
| 2021-09-30 | $19.26M | 162.79% |
| 2021-06-30 | $7.33M | -38.43% |
| 2021-03-31 | $11.90M | 20.15% |
| 2020-12-31 | $9.90M | -46.27% |
| 2020-09-30 | $18.43M | -83.23% |
| 2020-06-30 | $109.89M | - |
| 2020-03-31 | $109.89M | - |
2seventy bio generated $8.97M in revenue during Q2 2024, up -27.89% compared to the previous quarter, and up 21.54% compared to the same period a year ago.
2seventy bio Revenue Breakdown
2seventy bio Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Royalty And Other Revenue | $4.64M | $6.22M | - |
| Service | $24.14M | $55.49M | $21.38M |
| Collaboration Arrangement | - | $19.58M | - |
2seventy bio's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (83.87%), and Royalty And Other Revenue (16.13%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Service | $7.72M | $8.30M | $5.02M | $10.83M | $41.13M | $4.64M | $5.67M | $4.05M | $3.84M | $6.31M |
| Royalty And Other Revenue | - | $1.23M | $1.99M | $1.42M | $1.12M | $863.00K | $781.00K | $887.00K | $803.00K | $608.00K |
2seventy bio's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Service (100.00%).
2seventy bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SRPT | Sarepta Therapeutics | $1.24B | $413.46M |
| ASND | Ascendis Pharma | $266.72M | $95.89M |
| PBYI | Puma Bio | $235.64M | $47.08M |
| RCUS | Arcus Biosciences | $117.00M | $39.00M |
| TSVT | 2seventy bio | $100.39M | $8.97M |
| PTGX | Protagonist Therapeutics | $60.00M | $4.17M |
| MRSN | Mersana Therapeutics | $36.85M | $2.29M |
| RLAY | Relay Therapeutics | $25.55M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| KZR | Kezar Life Sciences | $7.00M | - |
| KDNY | Chinook Therapeutics | $6.13M | $1.01M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| PLRX | Pliant Therapeutics | $1.58M | - |
| IOVA | Iovance Biotherapeutics | $1.19M | $31.11M |
| PHAT | Phathom Pharmaceuticals | $682.00K | $1.91M |
| CGEM | Cullinan Oncology | - | - |
| DAWN | Day One Biopharmaceuticals | - | $20.07M |
| DICE | DICE Therapeutics | - | - |
| INZY | Inozyme Pharma | - | - |
| REPL | Replimune Group | - | - |
| SNDX | Syndax Pharmaceuticals | - | $3.50M |
| ZNTL | Zentalis Pharmaceuticals | - | - |
TSVT Revenue FAQ
What is 2seventy bio’s yearly revenue?
2seventy bio's yearly revenue for 2023 was $100.39M, representing an increase of 9.72% compared to 2022. The company's yearly revenue for 2022 was $91.5M, representing an increase of 67.81% compared to 2021. TSVT's yearly revenue for 2021 was $54.52M, representing a decrease of -78.03% compared to 2020.
What is 2seventy bio’s quarterly revenue?
2seventy bio's quarterly revenue for Q2 2024 was $8.97M, a -27.89% decrease from the previous quarter (Q1 2024), and a -75.12% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $12.44M, a 16.39% increase from the previous quarter (Q4 2023), and a -70.12% decrease year-over-year (Q1 2023). TSVT's quarterly revenue for Q4 2023 was $10.68M, a -11.22% decrease from the previous quarter (Q3 2023), and a -80.98% decrease year-over-year (Q4 2022).
What is 2seventy bio’s revenue growth rate?
2seventy bio's revenue growth rate for the last 3 years (2021-2023) was 84.12%, and for the last 5 years (2019-2023) was 126.63%.
What are 2seventy bio’s revenue streams?
2seventy bio's revenue streams in c 23 are Royalty And Other Revenue, and Service. Royalty And Other Revenue generated $4.64M in revenue, accounting 16.13% of the company's total revenue, down -25.37% year-over-year. Service generated $24.14M in revenue, accounting 83.87% of the company's total revenue, down -56.49% year-over-year.
What is 2seventy bio’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of 2seventy bio was Service. This segment made a revenue of $24.14M, representing 83.87% of the company's total revenue.